Skip to Main content Skip to Navigation
New interface
Journal articles

Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions

Abstract : Liraglutide, an anti-diabetic drug and agonist of the glucagon-like peptide one receptor (GLP1R), has recently been approved to treat obesity in individuals with or without type 2 diabetes. Despite its extensive metabolic benefits, the mechanism and site of action of liraglutide remain unclear. Here, we demonstrate that liraglutide is shuttled to target cells in the mouse hypothalamus by specialized ependymoglial cells called tanycytes, bypassing the blood-brain barrier. Selectively silencing GLP1R in tanycytes or inhibiting tanycytic transcytosis by botulinum neurotoxin expression not only hampers liraglutide transport into the brain and its activation of target hypothalamic neurons, but also blocks its anti-obesity effects on food intake, body weight and fat mass, and fatty acid oxidation. Collectively, these striking data indicate that the liraglutide-induced activation of hypothalamic neurons and its downstream metabolic effects are mediated by its tanycytic transport into the mediobasal hypothalamus, strengthening the notion of tanycytes as key regulators of metabolic homeostasis.
Complete list of metadata
Contributor : Frank Pfrieger Connect in order to contact the contributor
Submitted on : Monday, September 26, 2022 - 12:37:50 PM
Last modification on : Tuesday, November 22, 2022 - 2:26:16 PM




Monica Imbernon, Chiara Saponaro, Hans Christian Cederberg Helms, Manon Duquenne, Daniela Fernandois, et al.. Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions. Cell Metabolism, 2022, 34 (7), pp.1054 - 1063.e7. ⟨10.1016/j.cmet.2022.06.002⟩. ⟨hal-03778811⟩



Record views